Guillaume Moreau

Physioquanta

Founder & CEO

Description

Guillaume Moreau is a pioneering figure in the field of health technology and longevity research, with over 35 years of expertise in photobiomodulation (PBM). As the founder and CEO of Physioquanta, he has been at the forefront of developing innovative health solutions aimed at extending healthy human lifespans. Moreau's journey began with his training at the Moscow Energy Institute, after which he introduced PBM technology to France. His groundbreaking work led to the creation of Milta 2.0 in 2024, a CE-certified medical device that combines nano-pulsed cold laser, LED emissions, and static magnetic fields. This technology shows immense potential for cellular rejuvenation and tissue repair, key areas of interest in longevity research. In addition to Physioquanta, Moreau has expanded his influence in the longevity field through his roles in other innovative companies: Regenlife: As a co-founder, Moreau has been instrumental in developing this company's focus on neurodegenerative diseases. Regenlife's work in creating non-invasive medical devices for brain stimulation aligns closely with longevity goals, potentially offering new avenues for maintaining cognitive health in aging populations. Through these ventures, Moreau continues to advance research and applications in diverse healthcare domains, including skin rejuvenation, hair restoration, neurological health, and personalized nutrition. His work exemplifies the growing synergy between advanced health technologies and longevity research, offering exciting possibilities for enhancing human health and extending lifespans through innovative, non-invasive approaches. Moreau's participation in the Tech for Longevity event underscores the significant potential of his multifaceted work in the pursuit of extended healthspans. His comprehensive approach, spanning from cellular-level interventions to personalized nutrition, positions him as a key figure in the evolving landscape of longevity science and technology.